Peltola MT - Search Results

1

A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.

Waters KM, Stram DO, Le Marchand L, Klein RJ, Valtonen-André C, Peltola MT, Kolonel LN, Henderson BE, Lilja H, Haiman CA. Waters KM, et al. Among authors: peltola mt. Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2639-46. doi: 10.1158/1055-9965.EPI-10-0427. Epub 2010 Aug 24. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20736317 Free PMC article.

2

Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.

Haiman CA, Stram DO, Vickers AJ, Wilkens LR, Braun K, Valtonen-André C, Peltola M, Pettersson K, Waters KM, Marchand LL, Kolonel LN, Henderson BE, Lilja H. Haiman CA, et al. J Natl Cancer Inst. 2013 Feb 6;105(3):237-43. doi: 10.1093/jnci/djs486. Epub 2012 Dec 3. J Natl Cancer Inst. 2013. PMID: 23213189 Free PMC article.

3

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication.

Vickers A, Cronin A, Roobol M, Savage C, Peltola M, Pettersson K, Scardino PT, Schröder F, Lilja H. Vickers A, et al. J Clin Oncol. 2010 May 20;28(15):2493-8. doi: 10.1200/JCO.2009.24.1968. Epub 2010 Apr 26. J Clin Oncol. 2010. PMID: 20421547 Free PMC article. Clinical Trial.

4

A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam.

Vickers AJ, Cronin AM, Roobol MJ, Savage CJ, Peltola M, Pettersson K, Scardino PT, Schröder FH, Lilja H. Vickers AJ, et al. Clin Cancer Res. 2010 Jun 15;16(12):3232-9. doi: 10.1158/1078-0432.CCR-10-0122. Epub 2010 Apr 16. Clin Cancer Res. 2010. PMID: 20400522 Free PMC article.

5

Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy.

Bicak M, Lückerath K, Kalidindi T, Phelps ME, Strand SE, Morris MJ, Radu CG, Damoiseaux R, Peltola MT, Peekhaus N, Ho A, Veach D, Malmborg Hager AC, Larson SM, Lilja H, McDevitt MR, Klein RJ, Ulmert D. Bicak M, et al. Among authors: peltola mt. Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15172-15181. doi: 10.1073/pnas.1918744117. Epub 2020 Jun 12. Proc Natl Acad Sci U S A. 2020. PMID: 32532924 Free PMC article.

6

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.

Gupta A, Roobol MJ, Savage CJ, Peltola M, Pettersson K, Scardino PT, Vickers AJ, Schröder FH, Lilja H. Gupta A, et al. Br J Cancer. 2010 Aug 24;103(5):708-14. doi: 10.1038/sj.bjc.6605815. Epub 2010 Jul 27. Br J Cancer. 2010. PMID: 20664589 Free PMC article.

7

Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?

Carlsson SV, Peltola MT, Sjoberg D, Schröder FH, Hugosson J, Pettersson K, Scardino PT, Vickers AJ, Lilja H, Roobol MJ. Carlsson SV, et al. Among authors: peltola mt. BJU Int. 2013 Sep;112(5):602-9. doi: 10.1111/j.1464-410X.2012.11690.x. Epub 2013 Feb 28. BJU Int. 2013. PMID: 23448270 Free PMC article. Clinical Trial.

8

Quantitative Time-Resolved Fluorescence Imaging of Androgen Receptor and Prostate-Specific Antigen in Prostate Tissue Sections.

Krzyzanowska A, Lippolis G, Helczynski L, Anand A, Peltola M, Pettersson K, Lilja H, Bjartell A. Krzyzanowska A, et al. J Histochem Cytochem. 2016 May;64(5):311-22. doi: 10.1369/0022155416640466. Epub 2016 Mar 29. J Histochem Cytochem. 2016. PMID: 27026295 Free PMC article.

9

Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys(₁₄₅) or Lys(₁₄₆) from fPSA without internal cleavages at Lys(₁₄₅) or Lys(₁₄₆).

Peltola MT, Niemelä P, Alanen K, Nurmi M, Lilja H, Pettersson K. Peltola MT, et al. J Immunol Methods. 2011 Jun 30;369(1-2):74-80. doi: 10.1016/j.jim.2011.04.006. Epub 2011 Apr 28. J Immunol Methods. 2011. PMID: 21554885 Free PMC article.

10

Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments.

Väisänen V, Peltola MT, Lilja H, Nurmi M, Pettersson K. Väisänen V, et al. Among authors: peltola mt. Anal Chem. 2006 Nov 15;78(22):7809-15. doi: 10.1021/ac061201+. Anal Chem. 2006. PMID: 17105175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters